Article | August 16, 2021

Trends in Cold Chain Storage For Biologics

By Joe Cintavey, product specialist, Gore PharmBIO Products

Gene therapy iStock-1300754583

Packaging is critical, as biotechnology products become more valuable and require colder storage.

It is an exciting time for the biologics industry as new vaccines, monoclonal antibodies, mRNA therapies (or RNA therapies) and cell and gene therapies rapidly move into clinical use. These drugs are helping fight COVID-19 and providing completely new treatment options for diseases like cancer.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.

Subscribe to Cell & Gene X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Cell & Gene